Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in the double-blind (participant and investigator), dose-ranging, interventional Part 2 (Treatment).
Epistemonikos ID: 850f7228c426a48dac7759c0176e7e43265b69a8
First added on: Dec 23, 2025